Eli Lilly and Company (ETR:LLY)
786.00
-28.20 (-3.46%)
Nov 7, 2025, 5:35 PM CET
Eli Lilly and Company Employees
Eli Lilly and Company had 47,000 employees as of December 31, 2024. The number of employees increased by 4,000 or 9.30% compared to the previous year.
Employees
47,000
Change (1Y)
4,000
Growth (1Y)
9.30%
Revenue / Employee
€1,077,521
Profits / Employee
€333,886
Market Cap
714.77B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 47,000 | 4,000 | 9.30% |
| Dec 31, 2023 | 43,000 | 4,000 | 10.26% |
| Dec 31, 2022 | 39,000 | 4,000 | 11.43% |
| Dec 31, 2021 | 35,000 | 0 | - |
| Dec 31, 2020 | 35,000 | 1,375 | 4.09% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Fresenius SE & Co. KGaA | 176,486 |
| Fresenius Medical Care AG | 111,513 |
| Bayer Aktiengesellschaft | 91,864 |
| Siemens Healthineers AG | 73,800 |
| Merck KGaA | 59,020 |
| Fielmann Group AG | 24,363 |
| Sartorius Aktiengesellschaft | 13,528 |
| Carl Zeiss Meditec AG | 5,730 |
Eli Lilly and Company News
- 11 hours ago - Eli Lilly (LLY) Partners with SanegeneBio for Metabolic Disease Research - GuruFocus
- 18 hours ago - Huge News for Eli Lilly Stock and Novo Nordisk Stock Investors as Companies Make Deal With Trump - Nasdaq
- 1 day ago - Eli Lilly (LLY) Enters $1.2B RNAi Therapeutics Deal with SanegeneBio - GuruFocus
- 1 day ago - Eli Lilly inks a licensing deal worth up to $1.2B for RNAi therapeutics - Seeking Alpha
- 1 day ago - Eli Lilly And These AI Plays Lead 5 Stocks Near Buy Points - Investor's Business Daily
- 1 day ago - Eli Lilly's Breakout Is Here - Growing GLP-1 Market Share - Seeking Alpha
- 1 day ago - Prediction: Eli Lilly Will Be Worth More Than Berkshire Hathaway by 2030 - The Motley Fool
- 1 day ago - Eli Lilly Strikes a Landmark Pricing Deal With the U.S. for Its Billion-Dollar Weight Loss Drugs. Here's What This Means for Investors. - The Motley Fool